Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
Top Cited Papers
Open Access
- 4 January 2013
- journal article
- review article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 105 (4), 256-265
- https://doi.org/10.1093/jnci/djs629
Abstract
The therapeutic application of ionizing radiation has been largely based on its cytocidal power combined with the ability to selectively target tumors. Radiotherapy effects on survival of cancer patients are generally interpreted as the consequence of improved local control of the tumor, directly decreasing systemic spread. Experimental data from multiple cancer models have provided sufficient evidence to propose a paradigm shift, whereby some of the effects of ionizing radiation are recognized as contributing to systemic antitumor immunity. Recent examples of objective responses achieved by adding radiotherapy to immunotherapy in metastatic cancer patients support this view. Therefore, the traditional palliative role of radiotherapy in metastatic disease is evolving into that of a powerful adjuvant for immunotherapy. This combination strategy adds to the current anticancer arsenal and offers opportunities to harness the immune system to extend survival, even among metastatic and heavily pretreated cancer patients. We briefly summarize key evidence supporting the role of radiotherapy as an immune adjuvant. A critical appraisal of the current status of knowledge must include potential immunosuppressive effects of radiation that can hamper its capacity to convert the irradiated tumor into an in situ, individualized vaccine. Moreover, we discuss some of the current challenges to translate this knowledge to the clinic as more trials testing radiation with different immunotherapies are proposed.Keywords
This publication has 121 references indexed in Scilit:
- The Tipping Point for Combination Therapy: Cancer Vaccines With Radiation, Chemotherapy, or Targeted Small Molecule InhibitorsSeminars in Oncology, 2012
- Radiation-inducible Immunotherapy for Cancer: Senescent Tumor Cells as a Cancer VaccineMolecular Therapy, 2012
- Expression of tumour-specific antigens underlies cancer immunoeditingNature, 2012
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trialsThe Lancet, 2011
- Radiation Enhances Regulatory T Cell RepresentationInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Chemotherapy and radiotherapy: Cryptic anticancer vaccinesSeminars in Immunology, 2010
- Systemic effects of local radiotherapyThe Lancet Oncology, 2009
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002